Loading clinical trials...
Loading clinical trials...
Phase II Study of ASP3550 - A Maintenance-dose Finding Study in Patients With Prostate Cancer
Conditions
Interventions
ASP3550
Locations
8
Japan
Chugoku, Japan
Chūbu, Japan
Hokkaido, Japan
Kansai, Japan
Kanto, Japan
Kyusyu, Japan
Start Date
October 1, 2007
Primary Completion Date
October 1, 2009
Completion Date
October 1, 2009
Last Updated
October 29, 2014
NCT07225946
NCT04868604
NCT00756665
NCT05743621
NCT04104776
NCT06242119
Lead Sponsor
Astellas Pharma Inc
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions